Purple Innovation Reports Third Quarter 2025 Results

Purple Achieves Improved Net Loss and Positive Adjusted EBITDA, Advancing Its Profitability Turnaround Rejuvenate 2.0 Drives Continued Product and Brand Momentum Mattress Firm Rollout Remains on Track, Supporting Growth in Premium Segment , /PRNewswire/ -- Purple Innovation, Inc. (NASDAQ: PRPL) ("Purple"), a comfort innovation company whose mattresses promise to give you "less pain, better sleep," today announced results for the third quarter ended September 30, 2025. "Our third quarter results reflect the continued progress we're making in strengthening Purple's foundation and positioning the company for sustainable, profitable growth," said Rob DeMartini, CEO of Purple Innovation. "We delivered results in line with expectations, achieving an improved net loss and positive adjusted EBITDA and a sequential improvement in gross margin despite tariff headwinds. These results highlight the discipline and focus that are driving improved performance across our business." DeMartini continued, "One year after launching our restructuring program, Purple is a leaner, more agile company that is now firmly focused on scaling for growth. The success of Rejuvenate 2.0, the ongoing expansion of our Mattress Firm partnership, and strong showroom performance all underscore the power of our innovation and our brand momentum, marking an important inflection point in sales trends after consecutive quarters of year-over-year declines. We are entering the final months of the year with confidence, executing against our Path to Premium Sleep strategy and remaining on track to deliver positive adjusted EBITDA for the full year." Third Quarter 2025 Financial ResultsThird quarter 2025 net revenue was $118.8 million, up slightly compared to $118.6 million in the third quarter of 2024, fueled by the timing of Rejuvenate 2.0 shipments and the continued expansion of our Mattress Firm partnership. Strength across showroom and wholesale channels was partially offset by softer performance in e-commerce. Gross profit for the third quarter increased to $50.9 million or 42.8% of net revenue, compared to $35.2 million or 29.7% in the prior year period. Adjusted gross margin, which excludes restructuring and related charges, expanded by 230 basis points to 42.8% in the quarter, compared to 40.5% in the year-prior period. With the restructuring now complete, we also benefited as product continues to scale at our Georgia facility, and we delivered greater manufacturing efficiencies and direct material cost savings. Third quarter operating expenses were $63.0 million, down 23.2% from $82.0 million in the prior year quarter. The improvement was primarily driven by the comparison to significant restructuring, impairment, and related charges recorded last year, which declined by $13.6 million. Adjusted operating expenses, which excludes certain restructuring and impairment charges, were $57.7 million, down $5.4 million from the prior year period. Net loss attributable to Purple Innovation, Inc. for the third quarter was $11.7 million, a decline from $39.2 million in the prior year. Adjusted EBITDA for the third quarter was $0.2 million, an improvement from $(6.4) million last year, driven primarily by our strong gross margin performance and disciplined cost management. Balance SheetAs of September 30, 2025, the Company had cash and cash equivalents of $32.4 million compared to $29.0 million as of December 31, 2024. Net inventories as of September 30, 2025, totaled $65.8 million, up 9.8% compared to September 30, 2024, and an increase of 15.7% compared to December 31, 2024. 2025 OutlookThe Company is maintaining its 2025 guidance, projecting full-year revenue of $465 to $485 million and adjusted EBITDA of breakeven to $10 million, supported by the strong performance of the Rejuvenate 2.0 mattress launch and the successful rollout of the Mattress Firm partnership. Conference Call and Webcast InformationPurple Innovation, Inc. will host a live conference call to discuss financial results today, November 4, 2025, at 4:30 p.m. Eastern Time. To access the call dial 800-715-9871 (domestic) or 646-307-1963 (international). The call is also being webcast and can be accessed on the investor relations section of the Company's website, investors.purple.com. After the conference call, a webcast replay will remain available on the investor relations section of the Company's website for 30 days. About Purple Purple is a premium mattress company and the leader in sleep technology. Their patented GelFlex Grid® is the only material that instantly relieves pressure for less pain and better sleep. With over 30 years of innovation, Purple's product engineers are paving the way for everyone to experience a proven, deeper sleep by reducing their aches and pains. The GelFlex Grid® does it all—it instantly adapts as you move, balances temperature, relieves pressure, and offers support in all the right places. Purple products, including mattresses, pillows, cushions, frames, sheets, and more, can be found online at Purple.com, in 55 Purple stores, and over 3,800 retailers nationwide. PurpleLess pain. Better sleep. Forward Looking StatementsCertain statements made in this release that are not historical facts are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Statements based on historical data are not intended and should not be understood to indicate the Company's expectations regarding future events. Forward-looking statements provide current expectations or forecasts of future events or determinations. These statements include, but are not limited to, statements regarding our innovation pipeline, the timing of new product collection launches, our ability to improve profitability and optimize our business, the expansion of and benefits to us from our commercial relationship with Mattress Firm, the impact of other commercial relationships, including those with Walmart, Costco, and other traditional and non-traditional partners, revenue-to-date for the third quarter, our ability to drive profitable growth and create shareholder value, and our outlook for revenue and adjusted EBITDA for the full year 2025. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Factors that could influence the realization of forward-looking statements include, among others: changes in economic, financial and end-market conditions in the markets in which we operate; fluctuations in raw material prices and cost of labor; the financial condition of our customers and suppliers; competitive pressures, including the need for technology improvement, successful new product development and introduction; changes in consumer demand, including pullbacks in consumer spending; disruptions to our manufacturing processes; and the risk factors outlined in the "Risk Factors" section of our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 14, 2025, and in our other filings made with the SEC. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Non-GAAP Financial MeasuresEBITDA, adjusted operating expenses, adjusted EBITDA, adjusted gross margin, adjusted net income, and adjusted net income per diluted share are non-GAAP financial measures that remove the impact of certain non-cash and non-recurring costs. Management believes that the use of such non-GAAP financial measures provides investors with additional useful information with respect to the impact of various adjustments, which we view as a better measure of our operating performance. Refer to the attached table for the reconciliation of such non-GAAP financial measures to the most comparable GAAP financial measure. With respect to the Company's Adjusted EBITDA outlook for the full year 2025, a quantitative reconciliation to the corresponding GAAP information cannot be provided without unreasonable effort because of the inherent difficulty of accurately forecasting the occurrence and financial impact of the various adjusting items necessary for such reconciliation that have not yet occurred, are out of our control, or cannot be reasonably predicted, including but not limited to warrant liabilities and stock based compensation. For the same reasons, the Company is unable to assess the probable significance of the unavailable information, which could have a material impact on its future GAAP financial results. Investor Contact:Stacy Turnof, Edelman Smithfield[email protected]917-362-2581 PURPLE INNOVATION, INC. Condensed Consolidated Balance Sheets (unaudited – in thousands, except for par value) September 30, December 31, 2025 2024 Assets Current assets: Cash and cash equivalents $ 32,358 $ 29,011 Accounts receivable, net 25,210 33,057 Inventories 65,770 56,863 Prepaid expenses 7,401 6,023 Other current assets 5,667 1,414 Total current assets 136,406 126,368 Property and equipment, net 79,495 93,874 Operating lease right-of-use assets 70,668 75,516 Intangible assets, net 6,895 8,890 Other long-term assets 8,657 3,197 Total assets $ 302,121 $ 307,845 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 35,661 $ 40,639 Accrued compensation 7,765 9,415 Customer prepayments 5,209 6,411 Accrued rebates and allowances 13,820 10,013 Accrued warranty liabilities – current portion 7,635 6,114 Operating lease obligations – current portion 16,379 15,661 Other current liabilities 10,628 12,750 Total current liabilities 97,097 101,003 Related party debt 102,889 55,394 Accrued warranty liabilities, net of current portion 24,163 26,091 Operating lease obligations, net of current portion 80,837 87,072 Warrant liabilities 22,032 16,067 Other long-term liabilities 2,010 2,009 Total liabilities 329,028 287,636 Commitments and contingencies (Note 13) Stockholders' equity (deficit): Class A common stock; $0.0001 par value, 210,000 shares authorized; 108,246 issued and outstanding at September 30, 2025, and 107,545 issued and outstanding at December 31, 2024 11 11 Class B common stock; $0.0001 par value, 90,000 shares authorized; 163 issued and outstanding at September 30, 2025, and at December 31, 2024 — — Additional paid-in capital 595,118 594,053 Accumulated deficit (622,068) (573,866 Total stockholders' equity (deficit) attributable to Purple Innovation, Inc. (26,939) 20,198 Noncontrolling interest 32 11 Total stockholders' equity (deficit) (26,907) 20,209 Total liabilities and stockholders' equity (deficit) $ 302,121 $ 307,845 PURPLE INNOVATION, INC. Condensed Consolidated Statements of Operations (unaudited – in thousands, except per share amounts) Three Months Ended Nine Months Ended September 30, September 30, 2025 2024 2025 2024 Revenues, net $ 118,766 $ 118,598 $ 328,037 $ 358,902 Cost of revenues: Cost of revenues 67,915 70,546 197,462 220,190 Cost of revenues - restructuring related charges — 12,859 995 12,859 Total cost of revenues 67,915 83,405 198,457 233,049 Gross profit 50,851 35,193 129,580 125,853 Operating expenses: Marketing and sales 40,120 42,939 107,362 125,778 General and administrative 15,200 17,266 44,678 55,111 Research and development 2,367 2,920 6,997 10,572 Restructuring, impairment and other related charges 5,290 18,881 11,387 18,881 Total operating expenses 62,977 82,006 170,424 210,342 Operating loss (12,126) (46,813) (40,844) (84,489) Other income (expense): Interest expense (8,203) (4,394) (20,424) (13,029) Other income, net 1,742 7,165 1,812 11,612 Loss on extinguishment of debt — — — (3,394) Change in fair value – warrant liabilities 6,892 4,795 11,319 (111) Total other income (expense), net 431 7,566 (7,293) (4,922) Net loss before income taxes (11,695) (39,247) (48,137) (89,411) Income tax expense (53) (63) (148) (176) Net loss (11,748) (39,310) (48,285) (89,587) Net loss attributable to noncontrolling interest (28) (82) (83) (169) Net loss attributable to Purple Innovation, Inc. $ (11,720) $ (39,228) $ (48,202) $ (89,418) Net loss per share: Basic $ (0.11) $ (0.36) $ (0.45) $ (0.84) Diluted $ (0.11) $ (0.36) $ (0.45) $ (0.84) Weighted average common shares outstanding: Basic 108,245 107,508 108,026 107,008 Diluted 108,409 107,508 108,191 107,008 PURPLE INNOVATION, INC. Condensed Consolidated Statements of Cash Flows (unaudited – in thousands) Nine Months EndedSeptember 30, 2025 2024 Cash flows from operating activities: Net loss $ (48,285) $ (89,587) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization 19,659 27,448 Non-cash interest 9,537 5,303 Paid-in-kind interest 11,266 7,028 Non-cash restructuring, impairment and other related charges 3,775 20,115 Loss on extinguishment of debt — 3,394 Loss on disposal of property and equipment 318 770 Change in fair value – warrant liabilities (11,319) 111 Stock-based compensation 1,265 2,108 Changes in operating assets and liabilities: Accounts receivable 7,847 8,140 Inventories (8,907) 2,971 Prepaid expenses and other assets 755 378 Operating leases, net (2,080) (2,105) Accounts payable (4,464) (16,558) Accrued compensation (1,650) 10,045 Customer prepayments (1,202) (1,940) Accrued rebates and allowances 307 (3,203) Accrued warranty liabilities (407) (621) Other accrued liabilities (4,445) 1,592 Net cash used in operating activities (28,030) (24,611) Cash flows from investing activities: Sale of property and equipment 464 — Purchase of property and equipment (6,076) (6,160) Investment in intangible assets (454) (221) Net cash used in investing activities (6,066) (6,381) Cash flows from financing activities: Proceeds from related party loan 39,000 61,000 Payments on term loan — (25,000) Payments on revolving line of credit — (5,000) Payments for debt issuance costs (1,557) (3,466) Net cash provided by financing activities 37,443 27,534 Net increase (decrease) in cash and cash equivalents 3,347 (3,458) Cash and cash equivalents, beginning of the year 29,011 26,857 Cash and cash equivalents, end of the period $ 32,358 $ 23,399 PURPLE INNOVATION, INC. RECONCILIATION OF GAAP TO NON-GAAP MEASURES (In thousands) Management believes that the use of the following non-GAAP financial measures provides investors with additional useful information with respect to the impact of various adjustments, which we view as a better measure of our operating performance. These non-GAAP financial measures are EBITDA, adjusted EBITDA, adjusted operating expenses, adjusted net loss and adjusted net loss per diluted share. Other companies may calculate these non-GAAP measures differently than we do. These non-GAAP measures have limitations as analytical tools, and you should not consider them in isolation or as a substitute for our financial results prepared in accordance with GAAP. Reconciliation of GAAP Net Income (Loss) to Non-GAAP EBITDA and Adjusted EBITDA A reconciliation of GAAP net income (loss) to the non-GAAP measures of EBITDA and adjusted EBITDA is provided below. EBITDA represents net income (loss) before interest expense, income tax expense, other income, net, and depreciation and amortization. Adjusted EBITDA represents EBITDA excluding costs incurred due to changes in the fair value of the warrant liability, debt extinguishment, stock-based compensation expense, restructuring related expenses, loss on project write-off, nonrecurring and debt issuance legal fees, Board special committee costs, executive interim and search costs, severance cost, showroom opening and closing costs and non-operating facility expense. We believe EBITDA and Adjusted EBITDA provide additional useful information with respect to the impact of various adjustments and provide meaningful measures of our operating performance. Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 GAAP net loss $ (11,748) (39,310) (48,285) (89,587) Interest expense 8,203 4,394 20,424 13,029 Income tax expense 53 63 148 176 Other income, net (1,742) (7,165) (1,812) (11,612) Depreciation and amortization 9,777 14,627 19,658 27,448 EBITDA 4,543 (27,391) (9,867) (60,546) Adjustments: Change in fair value - warrant liability (6,893) (4,795) (11,320) 111 Loss on extinguishment of debt — — 795 3,394 Stock-based compensation expense 420 791 1,265 2,108 Restructuring related charges 65 23,669 6,850 23,669 Loss on project write-off — — — 1,355 Non-recurring and debt issuance legal fees 310 16 655 940 Strategic alternative costs 698 — 1,958 — Executive interim and search costs — 409 — 3,383 Severance costs 82 202 1,652 1,086 Showroom opening and closing costs — 724 147 782 Non-operating facility expense 964 — 964 — Adjusted EBITDA $ 189 $ (6,375) $ (6,901) $ (23,718) Reconciliation of GAAP Gross Profit to Adjusted Gross Profit A reconciliation of GAAP gross profit to the non-GAAP measures of adjusted gross profit is provided below. Adjusted gross profit represents net revenue less adjusted cost of revenues. Adjusted cost of revenues represents cost of revenues excluding restructuring charges recorded in cost of revenues. We believe adjusted gross margin provides additional useful information with respect to the impact of the restructuring and provides meaningful measures of our operating performance. (in thousands) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Revenues, net $ 118,766 $ 118,598 $ 328,037 $ 358,902 Total cost of revenues 67,915 83,405 198,457 233,049 Restructuring charges in cost of revenues — (12,859) (995) (12,859) Adjusted cost of revenues 67,915 70,546 197,462 220,190 Adjusted gross profit $ 50,851 $ 48,052 $ 130,575 $ 138,712 Adjusted gross profit % 42.8 % 40.5 % 39.8 % 38.6 % Reconciliation of GAAP Operating Expenses to non-GAAP Adjusted Operating Expenses Our presentation of adjusted operating expenses assumes adjustments for certain nonrecurring items that we do not believe directly reflects our current core operations. Adjusted operating expenses is a supplemental measure of operating performance that does not represent, and should not be considered, alternatives to net loss and earnings per share, as calculated in accordance with GAAP. We believe adjusted operating expenses supplements GAAP measures and enables us to more effectively evaluate our performance period-over-period. A reconciliation of operating expenses, the most directly comparable GAAP measure, to adjusted operating expenses is set forth below: (in thousands, except per share amounts) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Total operating expenses $ 62,977 $ 82,006 $ 170,424 $ 210,342 Restructuring, impairment and other related charges (5,290) (18,881) (11,387) (18,881) Adjusted operating expenses $ 57,687 $ 63,125 $ 159,037 $ 191,461 Reconciliation of GAAP Net Loss to non-GAAP Adjusted Net Loss and Adjusted Net Loss per Diluted Share Our presentation of adjusted net loss assumes that all net loss is attributable to Purple Innovation, Inc. (i.e. there is no allocation of net loss to noncontrolling interests), which assumes the full exchange at the beginning of the period of all outstanding Paired Securities for shares of Class A common stock of Purple Innovation, Inc., adjusted for certain nonrecurring items that we do not believe directly reflect our core operations. Adjusted net loss per share, diluted, is calculated by dividing adjusted net loss by the total shares of Class A common stock outstanding plus any dilutive warrants, options and restricted stock as calculated in accordance with GAAP and assuming the full exchange of all outstanding Paired Securities as of the beginning of each period presented. Adjusted net loss and adjusted net loss per diluted share, are supplemental measures of operating performance that do not represent, and should not be considered, alternatives to net loss and earnings per share, as calculated in accordance with GAAP. We believe adjusted net loss and adjusted net loss per diluted share, supplement GAAP measures and enable us to more effectively evaluate our performance period-over-period. A reconciliation of net loss, the most directly comparable GAAP measure, to adjusted net loss and the computation of adjusted net loss per diluted share, are set forth below: (in thousands, except per share amounts) Three MonthsEnded September30, Nine MonthsEnded September 30, 2025 2024 2025 2024 Net loss $ (11,748) $ (39,310) $ (48,285) $ (89,587) Income tax (benefit) expense, as reported 53 63 148 176 Revenue reduction due to SGI Contract 941 — 1,568 — Change in fair value – warrant liabilities (6,892) (4,795) (11,319) 111 Loss on extinguishment of debt — — — 3,394 Restructuring related charges 5,290 32,682 12,382 32,682 Gain on insurance proceeds — (7,301) — (11,601) Board special committee fees 698 — 1,958 — Adjusted net loss before income taxes (11,658) (18,661) (43,548) (64,825) Adjusted income tax benefit(1) 3,026 4,833 11,279 16,790 Adjusted net loss $ (8,632) $ (13,828) $ (32,269) $ (48,035) Adjusted net loss per share, diluted $ (0.08) $ (0.13) $ (0.30) $ (0.45) Adjusted weighted-average shares outstanding, diluted(2) 108,409 107,703 108,191 107,203 (1) Represents the estimated effective tax rate of 25.9% for the three and nine months ended September 30, 2025 and 2024, applied to adjusted net income before income taxes. The estimated effective tax rates are what the Company would be subject to and consist of the combined federal statutory tax rate and the Company's blended state tax rates. (2) Assumes options and restricted stock units calculated in accordance with GAAP and the full exchange of all outstanding Paired Securities for shares of Class A common stock as of the beginning of the period. A reconciliation of net income (loss) per share, diluted, to adjusted net loss per diluted share is set forth below for the three and nine months ended September 30, 2025 and 2024: For the Three Months Ended September 30, 2025 September 30, 2024 Net Loss Weighted Average Shares, Diluted Net Incomeper Share, Diluted Net Loss Weighted Average Shares,Diluted Net Incomeper Share,Diluted Net loss attributable to Purple Innovation Inc.(1) $ (11,720) 108,409 (0.11) $ (39,228) 107,508 $ (0.36) Assumed exchange of shares(2) (28) — (82) 195 Net loss (11,748) (39,310) Adjustments to arrive at adjusted loss before taxes(3) 90 20,649 Adjusted loss before taxes (11,658) (18,661) Adjusted income tax benefit(4) 3,026 4,833 Adjusted net loss $ (8,632) 108,409 (0.08) $ (13,828) 107,703 $ (0.13) (1) Represents net loss attributable to Purple Innovation, Inc. and the associated weighted average diluted shares, of Class A common stock outstanding. For the three months ended September 30, 2025, the Paired Securities are included in the beginning weighted average shares, diluted. (2) Assumes the full exchange of all outstanding Paired Securities for shares of Class A common stock as of the beginning of the period if not already included in weighted average diluted shares in footnote (1) above. Also assumes the addition of net income attributable to noncontrolling interests corresponding with the assumed exchange of the Paired Securities for shares of Class A common stock. (3) Represents the total impact of all adjustments identified in the adjusted net income table above to arrive at adjusted income before income taxes. Also assumes the dilutive warrants, options and restricted stock as calculated in accordance with GAAP. (4) Represents the estimated effective tax rate of 25.9% for the three months ended September 30, 2025 and 2024, applied to adjusted net income before income taxes. The estimated effective tax rates are what the Company would be subject to and consist of the combined federal statutory tax rate and the Company's blended state tax rates assuming no valuation allowance. For the Nine Months Ended September 30, 2025 September 30, 2024 Net Income Weighted Average Shares, Diluted Net Income per Share,Diluted Net Income Weighted Average Shares,Diluted Net Income per Share,Diluted Net loss attributable to Purple Innovation Inc.(1) $ (48,202) 108,191 (0.45) $ (89,418) 107,008 $ (0.84) Assumed exchange of shares(2) (83) — (169) 195 Net loss (48,285) (89,587) Adjustments to arrive at adjusted loss before taxes(3) 4,737 24,762 Adjusted loss before taxes (43,548) (64,825) Adjusted income tax benefit(4) 11,279 16,790 Adjusted net loss $ (32,269) 108,191 (0.30) $ (48,035) 107,203 $ (0.45) (1) Represents net loss attributable to Purple Innovation, Inc. and the associated weighted average diluted shares, of Class A common stock outstanding. For the nine months ended September 30, 2025, the Paired Securities are included in the beginning weighted average shares, diluted. (2) Assumes the full exchange of all outstanding Paired Securities for shares of Class A common stock as of the beginning of the period if not already included in weighted average diluted shares in footnote (1) above. Also assumes the addition of net income attributable to noncontrolling interests corresponding with the assumed exchange of the Paired Securities for shares of Class A common stock. (3) Represents the total impact of all adjustments identified in the adjusted net income table above to arrive at adjusted income before income taxes. Also assumes the dilutive warrants, options and restricted stock as calculated in accordance with GAAP. (4) Represents the estimated effective tax rate of 25.9% for the nine months ended September 30, 2025 and 2024, applied to adjusted net income before income taxes. The estimated effective tax rates are what the Company would be subject to and consist of the combined federal statutory tax rate and the Company's blended state tax rates assuming no valuation allowance. SOURCE Purple Innovation, LLC

Purple Innovation Reports Third Quarter 2025 Results

FAQ

Why Bullish?

How important is it?

Why Short Term?

Related Companies

Related News